152 related articles for article (PubMed ID: 33833384)
1. Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated origin.
Batta K; Bossenbroek HM; Pemmaraju N; Wilks DP; Chasty R; Dennis M; Milne P; Collin M; Beird HC; Taylor J; Patnaik MM; Cargo CA; Somervaille TCP; Wiseman DH
Leukemia; 2021 Nov; 35(11):3299-3303. PubMed ID: 33833384
[No Abstract] [Full Text] [Related]
2. Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin.
Brunetti L; Di Battista V; Venanzi A; Schiavoni G; Martelli MP; Ascani S; Mecucci C; Tiacci E; Falini B
Leukemia; 2017 May; 31(5):1238-1240. PubMed ID: 28111467
[No Abstract] [Full Text] [Related]
3. Blastic plasmacytoid dendritic cell neoplasm with a history of cytopenia: A case report.
Yan M; Wang W; Cen X; Wang L; Sun Y; Wang B; Ou J; Nong L; Ren H; Zhu P; Wang M
Diagn Cytopathol; 2020 Nov; 48(11):1102-1106. PubMed ID: 32374950
[TBL] [Abstract][Full Text] [Related]
4. Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal origins of two aggressive neoplasms.
Patnaik MM; Lasho T; Howard M; Finke C; Ketterling RL; Al-Kali A; Pardanani A; Droin N; Gangat N; Tefferi A; Solary E
Blood Cancer J; 2018 Aug; 8(9):82. PubMed ID: 30190511
[No Abstract] [Full Text] [Related]
5. Blastic plasmacytoid dendritic cell neoplasm arising from clonal hematopoiesis.
Suma S; Sakata-Yanagimoto M; Nguyen TB; Hattori K; Sato T; Noguchi M; Nannya Y; Ogawa S; Watanabe R; Fujimoto M; Nakamura N; Kusakabe M; Nishikii H; Kato T; Chiba S
Int J Hematol; 2018 Oct; 108(4):447-451. PubMed ID: 29705980
[TBL] [Abstract][Full Text] [Related]
6. Chronic myelomonocytic leukemia and blastic plasmacytoid dendritic cell neoplasm. A case report and systematic review.
Espasa A; Sorigue M; Tapia G; Cabezon M; Vergara S; Raya M; Navarro JT; Junca J; Zamora L; Xicoy B
Cytometry B Clin Cytom; 2021 May; 100(3):292-295. PubMed ID: 32830878
[No Abstract] [Full Text] [Related]
7. TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm.
Jardin F; Ruminy P; Parmentier F; Troussard X; Vaida I; Stamatoullas A; Leprêtre S; Penther D; Duval AB; Picquenot JM; Courville P; Capiod JC; Tilly H; Bastard C; Marolleau JP
Br J Haematol; 2011 May; 153(3):413-6. PubMed ID: 21275969
[No Abstract] [Full Text] [Related]
8. Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients.
Khanlari M; Yin CC; Takahashi K; Lachowiez C; Tang G; Loghavi S; Bah I; Wang W; Konoplev S; Medeiros LJ; Pemmaraju N; Khoury JD; Wang SA
Leukemia; 2022 May; 36(5):1343-1350. PubMed ID: 35279700
[TBL] [Abstract][Full Text] [Related]
9. Recurrent Aortic Thromboembolism Associated With
Bukhari S; Saati A; Abuhalimeh B; Ouma G
J Investig Med High Impact Case Rep; 2024; 12():23247096231224366. PubMed ID: 38214069
[TBL] [Abstract][Full Text] [Related]
10. Blastic plasmacytoid dendritic cell neoplasm associated with chronic myelomonocytic leukemia.
Hu Z; Sun T
Blood; 2016 Sep; 128(12):1664. PubMed ID: 28092882
[No Abstract] [Full Text] [Related]
11. Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases.
Vitte F; Fabiani B; Bénet C; Dalac S; Balme B; Delattre C; Vergier B; Beylot-Barry M; Vignon-Pennamen D; Ortonne N; Algros MP; Carlotti A; Samaleire D; Frouin E; Levy A; Laroche L; Theate I; Monnien F; Mugneret F; Petrella T
Am J Surg Pathol; 2012 Sep; 36(9):1302-16. PubMed ID: 22895265
[TBL] [Abstract][Full Text] [Related]
12. Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia.
Geyer JT; Tam W; Liu YC; Chen Z; Wang SA; Bueso-Ramos C; Oak J; Arber DA; Hsi E; Rogers HJ; Levinson K; Bagg A; Hassane DC; Hasserjian RP; Orazi A
Mod Pathol; 2017 Sep; 30(9):1213-1222. PubMed ID: 28548124
[TBL] [Abstract][Full Text] [Related]
13. Neoplasms derived from plasmacytoid dendritic cells.
Facchetti F; Cigognetti M; Fisogni S; Rossi G; Lonardi S; Vermi W
Mod Pathol; 2016 Feb; 29(2):98-111. PubMed ID: 26743477
[TBL] [Abstract][Full Text] [Related]
14. Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients.
Coltro G; Mangaonkar AA; Lasho TL; Finke CM; Pophali P; Carr R; Gangat N; Binder M; Pardanani A; Fernandez-Zapico M; Robertson KD; Bosi A; Droin N; Vannucchi AM; Tefferi A; Hunter A; Padron E; Solary E; Patnaik MM
Leukemia; 2020 May; 34(5):1407-1421. PubMed ID: 31836856
[TBL] [Abstract][Full Text] [Related]
15. Srsf2
Xu JJ; Chalk AM; Wall M; Langdon WY; Smeets MF; Walkley CR
Leukemia; 2022 Dec; 36(12):2883-2893. PubMed ID: 36271153
[TBL] [Abstract][Full Text] [Related]
16. Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia.
Garcia-Gisbert N; Arenillas L; Roman-Bravo D; Rodriguez-Sevilla JJ; Fernández-Rodríguez C; Garcia-Avila S; Velez P; Gibert J; Fernández-Ibarrondo L; Salar A; Florensa L; Bellosillo B; Ferrer A; Calvo X
Leukemia; 2022 Dec; 36(12):2922-2926. PubMed ID: 36273104
[No Abstract] [Full Text] [Related]
17. The prognostic value of the interaction between ASXL1 and TET2 gene mutations in patients with chronic myelomonocytic leukemia: a meta-analysis.
Zhao W; Zhang C; Li Y; Li Y; Liu Y; Sun X; Liu M; Shao R
Hematology; 2022 Dec; 27(1):367-378. PubMed ID: 35306971
[TBL] [Abstract][Full Text] [Related]
18. Chronic myelomonocytic leukaemia followed by blastic plasmacytoid dendritic cell neoplasm.
Lebecque B; Vial JP; Pigneux A; Lechevalier N
Br J Haematol; 2019 May; 185(3):398. PubMed ID: 30784042
[No Abstract] [Full Text] [Related]
19. TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm.
Beird H; Yin CC; Khoury JD; Pierce S; Abbas HA; Zhao L; Skwarska A; Qazilbash M; Konopleva M; Futreal PA; Pemmaraju N
Blood Adv; 2023 May; 7(10):2000-2003. PubMed ID: 36689729
[No Abstract] [Full Text] [Related]
20. Blastic Plasmacytoid Dendritic Cell Neoplasm.
Khoury JD
Curr Hematol Malig Rep; 2018 Dec; 13(6):477-483. PubMed ID: 30350260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
